Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
8d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2012 · fourth_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $25,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Food Industry (safety, labeling, etc.)
H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R. 3214, to amend the Food and Drug Administration's mission; to Energy & Commerce. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2012 · fourth_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Food Industry (safety, labeling, etc.)
H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R. 3214, to amend the Food and Drug Administration's mission; to Energy & Commerce. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated; to Judiciary. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes; to Finance. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program; to Health, Education, Labor, & Pensions.
Client expense: $110,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $25,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $30,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $14,400
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Food Industry (safety, labeling, etc.)
H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R. 3214, to amend the Food and Drug Administration's mission; to Energy & Commerce. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.
Client expense: $110,000 · Firm income: Not reported
2012 · second_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Food Industry (safety, labeling, etc.)
H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R. 3214, to amend the Food and Drug Administration's mission; to Energy & Commerce. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.
Client expense: $110,000 · Firm income: Not reported
2012 · first_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $14,400
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $10,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Food Industry (safety, labeling, etc.)
S. 216 - Food Safety Accountability Act, a bill to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated; all provisions relating to dietary supplements H.R. 1364 - Free Speech About Science Act, a bill to amend the FD&CA concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements; all provisions relating to dietary supplements S. 1310 - Dietary Supplement Labeling Act, a bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements H.R. 2044 - Health Freedom Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes H.R. 2045 - Freedom of Health Speech Act, a bill to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients HR 2736 - Access to Medical Treatment Act, a bill to permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests, and for other purposes; all provisions relating to dietary supplements HR 2908 - Testimonial Free Speech Act, a bill to protect the First Amendment rights of individuals to share their experiences and perceptions of the effects of foods and dietary supplements HR 3204 - Guidance Accountability and Transparency Act, a bill to amend the Federal Food, Drug, and Cosmetic Act to ensure public participation in the drafting and issuance of Level 1 guidance documents, and for other purposes; all provisions relating to dietary supplements HR 3214 - Food and Drug Administration Mission Reform Act, a bill to amend the Food and Drug Administration's mission; all provisions relating to dietary supplements HR 3380 - Dietary Supplement Protection Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning safe dietary ingredients in dietary supplements New Dietary Ingredient Notification Guidance - Docket No. FDA-2011-D-0376, CFSAN 20117. Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues
2011 · fourth_quarter · Food Industry (safety, labeling, etc.)
S. 216 - Food Safety Accountability Act, a bill to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated; all provisions relating to dietary supplements H.R. 1364 - Free Speech About Science Act, a bill to amend the FD&CA concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements; all provisions relating to dietary supplements S. 1310 - Dietary Supplement Labeling Act, a bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements H.R. 2044 - Health Freedom Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes H.R. 2045 - Freedom of Health Speech Act, a bill to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients HR 2736 - Access to Medical Treatment Act, a bill to permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests, and for other purposes; all provisions relating to dietary supplements HR 2908 - Testimonial Free Speech Act, a bill to protect the First Amendment rights of individuals to share their experiences and perceptions of the effects of foods and dietary supplements HR 3204 - Guidance Accountability and Transparency Act, a bill to amend the Federal Food, Drug, and Cosmetic Act to ensure public participation in the drafting and issuance of Level 1 guidance documents, and for other purposes; all provisions relating to dietary supplements HR 3214 - Food and Drug Administration Mission Reform Act, a bill to amend the Food and Drug Administration's mission; all provisions relating to dietary supplements HR 3380 - Dietary Supplement Protection Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning safe dietary ingredients in dietary supplements New Dietary Ingredient Notification Guidance - Docket No. FDA-2011-D-0376, CFSAN 20117. Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues
2011 · fourth_quarter · Food Industry (safety, labeling, etc.)
H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.
Client expense: $110,000 · Firm income: Not reported
2011 · fourth_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $14,400
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Food Industry (safety, labeling, etc.)
H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.
Client expense: $110,000 · Firm income: Not reported
2011 · third_quarter · Food Industry (safety, labeling, etc.)
S. 216 - Food Safety Accountability Act, a bill to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated; all provisions relating to dietary supplements H.R. 1364 - Free Speech About Science Act, a bill to amend the FDCA concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements; all provisions relating to dietary supplements H.R. 2044 - Health Freedom Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes H.R. 2045 - Freedom of Health Speech Act, a bill to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients S. 1310 - Dietary Supplement Labeling Act, a bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements HR 2736 - Access to Medical Treatment Act, a bill to permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests, and for other purposes; all provisions relating to dietary supplements HR 2908 - Testimonial Free Speech Act, a bill to protect the First Amendment rights of individuals to share their experiences and perceptions of the effects of foods and dietary supplements. New Dietary Ingredient Notification Guidance - Docket No. FDA-2011-D-0376, CFSAN 20117. Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues
2011 · third_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Food Industry (safety, labeling, etc.)
H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2011 · second_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $14,400
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Health Issues
Dehydroepiandrosterone Abuse Reduction Act, Issues regarding dietary supplements Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues H.R.2044, Health Freedom Act, Issues regarding dietary supplements
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Food Industry (safety, labeling, etc.)
S. 216 - Food Safety Accountability Act, a bill to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated; all provisions relating to dietary supplements H.R. 1364 - Free Speech About Science Act, a bill to amend the FDCA concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements; all provisions relating to dietary supplements H.R. 2044 - Health Freedom Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes H.R. 2045 - Freedom of Health Speech Act, a bill to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients S. 1310 - Dietary Supplement Labeling Act, a bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements New Dietary Ingredient Notification Guidance - Docket No. FDA-2011-D-0376, CFSAN 20117. Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Client expense: $130,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $150,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Client expense: $130,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE